Literature DB >> 16317113

The amino terminus and the third extracellular loop of CX3CR1 contain determinants critical for distinct receptor functions.

Yiming Chen1, Simone R Green, Felicidad Almazan, Oswald Quehenberger.   

Abstract

The G protein-coupled receptor CX3CR1 is a specific receptor for the CX3C chemokine fractalkine (CX3CL1 according to the new chemokine nomenclature). The aim of this study was to identify receptor elements that contribute independently to agonist binding and receptor activation. Targeted mutation of selected acidic amino acid residues demonstrated that the binding activity of CX3CR1 was critically dependent on the two negatively charged residues Asp25 and Glu254 located on the N-terminal domain and third extracellular loop, respectively. In addition, mutation of the uncharged polar residue Tyr14 in the amino terminus caused a reduction in the ligand binding affinity. In contrast, the three acidic residues Glu13, Asp16, and Asp266 did not contribute to ligand binding but were crucial for receptor activation. The mutant receptors E13A, D16A, and D266A bound fractalkine with high affinity but were unable to induce signaling events necessary to support chemotaxis. These acidic residues may engage in electrostatic interactions with basic residues on fractalkine that are necessary for receptor function but not for binding. Our data are consistent with a model of chemokine receptor activation consisting of a multi-step mechanism. Step one mediates the high-affinity fractalkine binding involving Tyr14, Asp25, and Glu254. The initial interaction then triggers the engagement of Glu13, Asp16, and Asp266, which are necessary for CX3CR1 activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317113     DOI: 10.1124/mol.105.015909

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  5 in total

Review 1.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

2.  The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton.

Authors:  Whitney L Jamieson-Gladney; Yun Zhang; Alan M Fong; Olimpia Meucci; Alessandro Fatatis
Journal:  Breast Cancer Res       Date:  2011-09-20       Impact factor: 6.466

3.  N-terminal pyroglutamate formation in CX3CL1 is essential for its full biologic activity.

Authors:  Astrid Kehlen; Monique Haegele; Livia Böhme; Holger Cynis; Torsten Hoffmann; Hans-Ulrich Demuth
Journal:  Biosci Rep       Date:  2017-08-23       Impact factor: 3.840

4.  Activation of the human chemokine receptor CX3CR1 regulated by cholesterol.

Authors:  Minmin Lu; Wenli Zhao; Shuo Han; Xiaowen Lin; Tingyu Xu; Qiuxiang Tan; Mu Wang; Cuiying Yi; Xiaojing Chu; Weibo Yang; Ya Zhu; Beili Wu; Qiang Zhao
Journal:  Sci Adv       Date:  2022-06-29       Impact factor: 14.957

5.  CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.

Authors:  Gia Green; Sara M Johnson; Heather Costello; Kelsey Brakel; Olivia Harder; Antonius G Oomens; Mark E Peeples; Hong M Moulton; Stefan Niewiesk
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.